Clinical Trial Update: The Use of Dexmedetomidine for EEG Sedation in Children With Behavioural Disorders [Phase 2]

View source ↗

Summary

Phase 2 trial assessing dexmedetomidine for EEG sedation in children with behavioral disorders has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Behavior Disorders in Children
• Procedural Sedation

Drugs mentioned

• Dexmedetomidine (Dexmedetomidine)

Snippet

Sponsor: Azienda Ospedaliera di Padova | Conditions: Procedural Sedation, Behavior Disorders | Phase 2 | Status: COMPLETED | Results posted: 2021-01-15